Florida Research Institute is offering 200 people free liver evaluations through LiverMultiScan, a non-invasive diagnostic technology.
Primary biliary cholangitis (PBC) is a chronic liver disease resulting from progressive inflammation and destruction of the interlobular bile ducts.
Researchers believe that a re-classification of NAFLD, which affects nearly a billion people globally with no drug treatment currently on the market, is essential to improve patient understanding and industry funding to better mitigate its impact.
Our teams joined virtually to hear the latest insights from regulators including the FDA, thought-leading scientists and translational and biomarker experts in drug development.
NASH is characterized by fat accumulation and inflammation in the liver, which can lead to scarring and long-term damage.
